FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35222211000001106: Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106650601000001117 Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106650701000001110 Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Is a Co-careldopa 25mg/100mg tablets true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Is a Co-careldopa 25mg/100mg tablets false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Is a Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has active ingredient Levodopa false Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has basis of strength substance Levodopa true Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength numerator value 100 false Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) 90 tablet 9 x 10 tablets Has AMP True Co-careldopa 25mg/100mg tablets (Genesis Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start